EMEA-002997-PIP01-21

Table of contents

Key facts

Active substance
Immunoglobulin G1 anti-SORT1 human monoclonal antibody
Therapeutic area
Neurology
Decision number
P/0299/2021
PIP number
EMEA-002997-PIP01-21
Pharmaceutical form(s)
Solution for infusion
Condition(s) / indication(s)
Treatment of clinically symptomatic or pre-symptomatic frontotemporal dementia
Route(s) of administration
Intravenous use
Contact for public enquiries
Alector, Inc.

E-mail: info@alector.com
Tel: +1 4152315660

Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

How useful was this page?

Add your rating